Form 4: Aprea Therapeutics Director Seizinger Buys 10,000 Shares

Director Bernd R. Seizinger of Aprea Therapeutics, Inc. (APRE) purchased 10,000 shares of common stock at an average price of $2.68 on October 11, 2024.

Summary

• On October 11, 2024, Bernd R. Seizinger, a director of Aprea Therapeutics, Inc., acquired 10,000 shares of the company's common stock.
• The shares were purchased at a weighted average price of $2.68, with individual transaction prices ranging from $2.52 to $2.70.
• Following the transaction, Seizinger directly owns 44,730 shares of Aprea Therapeutics common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored by investors as an indicator of management's confidence in the company's prospects. It can be a positive signal, but should be considered alongside other factors when evaluating a company.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates